PerkinElmer to acquire TB test kit maker Oxford Immunotec for $591m

pharmanewsdaily- January 16, 2021 0

US medical diagnostic firm PerkinElmer has agreed to acquire Oxford Immunotec Global, a UK-based diagnostics company, for $22 per share or around $591 million. Oxford ... Read More